TMCnet News
Bullinadvantage.com: TLLE, UNDT, SAY, BZCN, ANSV "Bullinadvantage.com Alert"(M2 PressWIRE Via Acquire Media NewsEdge) RDATE:17122008 Bull in Advantage, LLC a.k.a. redhotpennystock.com names Teletouch Communications, Inc. (Pink Sheets: TLLE), Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), Satyam (NYSE: SAY), BizAuctions, Inc. (Pink Sheets: BZCN) and Anesiva, Inc. (Nasdaq: ANSV) its "Bullinadvantage.com Alert." visit our site at either http://bullinadvantage.com/ or http://redhotpennystock.com/ to sign up for our free ahead of the curve newsletter! _____________________________________________________________________ Teletouch Communications, Inc. (Pink Sheets: TLLE - http://finance.yahoo.com/q?s=TLLE.pk) Teletouch Communications, Inc. (Pink Sheets: TLLE), a leading U.S. cellular services provider and mobile electronics retailer, today announced preliminary consolidated results for its 2008 fiscal year. Having recently completed the audits and filing of its Annual Report on Form 10-K for the fiscal year ended May 31, 2007, the Company is releasing preliminary summary financial results for the fiscal year ended May 31, 2008. While the following financial information disclosures are also dated, they are current within the regulatory reporting cycle through the first two quarters, ending August 31 and November 30, 2008, respectively, of the Company's 2009 fiscal year. Investors are cautioned that this information has not been fully reviewed or audited, and that there may be changes to such information, possibly material in nature, after the audit is completed. For the year ended May 31, 2008, the Company announced the following preliminary summary financial information (2008 E - "Estimated"): Summary Results of Operations: (dollars, in millions) Year Ended May 31, Operating revenues: 2008 E 2007 Change Service, rent and maintenance revenue $ 28.9 $ 27.5 $ 1.4 Products sales revenue 25.6 28.7 (3.1 ) Total operating revenues 54.5 56.2 (1.7 ) Total operating expenses 53.4 61.5 (8.1 ) Operating income (loss) 1.1 (5.3 ) 6.4 EBITDA from continuing operations 2.6 (3.4 ) 6.0 Reconciliation to net loss from continuing operations: Depreciation and amortization 1.5 1.9 (0.4 ) Interest expense 3.9 3.7 0.2 Income tax expense 0.2 0.1 0.1 Net loss from continuing operations $ (3.0 ) $ (9.1 ) $ 6.1 Selected Balance Sheet Data: (dollars, in millions) May 31, 2008 E 2007 Change Cash 4.7 7.8 (3.1 ) Total Current Assets 20.0 22.4 (2.4 ) Total Assets 28.7 32.3 (3.6 ) Total Current Liabilities 29.9 46.5 (16.6 ) Total Liabilities 37.3 49.7 (12.4 ) The Company cautions shareholders and potential investors in the Company's securities that BDO Seidman, LLP, the Company's Independent Public Accountants, have not audited or reviewed these amounts and that such financial information is subject to further analysis and independent review. These results are preliminary and are subject to change, possibly material in nature, following completion of the audit for the year ended May 31, 2008. T. A. "Kip" Hyde, Jr., President and Chief Operating Officer stated, "Based on our current review of the 2008 fiscal year's numbers, we are pleased to report that we made substantial progress in turning the Company's previous financial situation and businesses around. Significant management actions taken during fiscal year 2008, certain of which are further disclosed and detailed in our recently filed 2007 10-K 'Subsequent Events' Notes, include: our settlement of a significant contract dispute with ATT (NYSE: T), our primary cellular carrier provider; increasing our overall operating credit facilities to $20 million; paying down certain long-term debt obligations to external warrant holders thereby retiring 6 million potentially dilutive shares; and effectively executing our integration and internal corporate restructuring plan, lowering SG&A and improving our operating margins, all of which are now reflected by the improvement in our financial results during the period. Following our acquisition of Progressive Concepts, Inc. in August of 2006, the transformation of Teletouch from a primarily paging company to a leading U.S. cellular services provider continues, but we have passed the tipping point on our goal of achieving positive consolidated EBITDA and Operating Earnings." Teletouch's Annual Report on Form 10-K for its year ended May 31, 2008 was due to be filed on August 29, 2008 but was delayed pending the completion of its 2007 Annual Report. The 2007 Annual Report was significantly delayed following the Company's acquisition of Progressive Concepts, Inc. ("PCI") in August 2006 due to previously announced accounting and audit issues encountered at PCI. Following the filing of the 2007 Annual Report on Form 10-K on November 26, 2008, the Company has made substantial progress toward the completion of the 2008 Annual Report. In its November 2008 announcement of the filing of the fiscal 2007 Annual Report, Teletouch reported that a significant amount of the audit work for fiscal 2008 had been completed at that time. The fiscal 2008 audit work continues to progress while Teletouch finishes drafting its 2008 Annual Report. Considering personnel and audit work scheduling during the upcoming holidays, Teletouch is targeting January 2009 for the completion of its 2008 Annual Report. Investors should be advised that the Company will not be current with its financial reporting requirements until it has completed its Quarterly Reports on Form 10-Q for all periods following the acquisition of PCI, up to and including the current fiscal year 2009 quarterly periods, and its Annual Report on Form 10-K for fiscal year 2008. The Company expects that the Quarterly Reports can be completed more efficiently upon the completion of the fiscal year 2008 Annual Report. Disclosure of Non-GAAP Financial Measures We report our financial results in accordance in accordance with generally accepted accounting principles ("GAAP"). However, management believes the presentation of certain non-GAAP financial measures provides useful information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations, and that when GAAP financial measures are viewed in conjunction with the non-GAAP financial measures, investors are provided with a more meaningful understanding of the Company's ongoing operating performance. In addition, these non-GAAP financial measures are among the primary indicators management uses as a basis for evaluating performance. For all non-GAAP financial measures in this release, we have provided corresponding GAAP financial measures for comparative purposes. We refer to the term "EBITDA from continuing operations" in various places of our financial discussion. EBITDA from continuing operations is defined by us as net income from continuing operations before interest expense, income tax expense, and depreciation and amortization expense. EBITDA from continuing operations is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative to operating profit, net income (loss) or cash flows from operating, investing or financing activities, each as determined in accordance with GAAP. You should also not consider EBITDA from continuing operations as a measure of liquidity. Moreover, since EBITDA from continuing operations are not measures determined in accordance with GAAP and thus are susceptible to varying interpretations and calculations, EBITDA from continuing operations, as presented, may not be comparable to similarly titled measures presented by other companies. About Teletouch Communications For more than 40 years, Teletouch has offered a comprehensive suite of telecommunications products and services including cellular, two-way radio, GPS-telemetry, wireless messaging and public safety/emergency response vehicle products and services throughout the U.S. Teletouch's wholly-owned subsidiary, Progressive Concepts, Inc. (PCI), is a leading provider of ATT Mobility(R) services (voice, data and entertainment), as well as other mobile, portable and personal electronics products and services to individuals, businesses and government agencies. PCI operates a chain of retail stores and sells under the "Hawk Electronics" brand; through Hawk-branded sub-agents; using its own direct sales force and through the Internet at various sites including: www.hawkelectronics.com and www.hawkexpress.com, among others. PCI also operates a national wholesale distribution business, known as PCI Wholesale, which serves smaller cellular and automotive retailers, car dealers and rural cellular carriers throughout the country; Dealers and Retailers see www.pciwholesale.com. Additional information on Teletouch's Emergency Vehicle Products group can be found at www.teletouchevp.com. Teletouch's common stock is traded Over-The-Counter under stock symbol: TLLE. Additional information about Teletouch can be found at www.teletouch.com. Universal Detection Technology (www.udetection.com) (OTCBB: UNDT - http://finance.yahoo.com/q?s=UNDT.ob) December 17th, 2008-- Universal Detection Technology (www.udetection.com) (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order for its anthrax detection equipment from the city of Calgary, Canada Police Service. The purchase order comes from the department's terrorism training division. The detection equipment is designed to check for anthrax and can return results in as little as 3 minutes. The Calgary Police Service, located in Calgary, Alberta, Canada, is made up of more than 1,600 police officers and 855 civilian members. Calgary is the largest city in the province of Alberta, Canada. The metropolitan population was 1,162,310 in 2006. A report released last week by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism says urgent security measures need to be taken soon or the world is likely to undergo an incident of terrorism using weapons of mass destruction within the next five years. "Unless the world community acts decisively and with great urgency, it is more likely than not that a weapon of mass destruction will be used in a terrorist attack somewhere in the world by the end of 2013," the report states in the opening sentence of the executive summary. The report also emphasizes the need of the new administration to prepare the nation against a future bioterrorist attack. TO WATCH A VIDEO OF THE REPORT PLEASE GO TO: http://cosmos.bcst.yahoo.com/up/player/popup/index.php?cl=10944062. UNDT's anthrax detection equipment has been extensively used by first responders and private industry throughout the country. The equipment has been evaluated by the U.S. DOD as well as the United Kingdom military. The equipment's capacities include: -- No cross-reactivity with near neighbor strains -- No cross-reactivity to household powders -- No set up time -- No expensive reader needed -- No decontamination requirements -- No false positives -- No false negatives -- No hook effect "This is our first purchase order from Canada as we expand marketing our products internationally," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer. UNDT has received the purchase orders referred to in this news release through Security Solutions International (SSI). The equipment was billed to the City of Calgary Police Service by SSI as part of participation in the counter-terrorism training at the Gulf Coast Terrorism Conference and has been delivered to them directly from UDT. For more information, please visit our website at www.udetection.com or Email us at [email protected]. About Universal Detection Technology Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com. Satyam (NYSE: SAY - http://finance.yahoo.com/q?s=SAY) December 16th, 2008-- Satyam Computer Services announced that it is not going ahead with its proposed acquisition of Maytas Properties and Maytas Infra, in light of the feedback received from the Investor community. Commenting on this decision, Satyam Chairman, Mr. Raju said, "We have been surprised by the market reaction to this decision even though we were quite positive about the merits of the acquisition. However, in deference to the views expressed by many investors, we have decided to call off these acquisitions." About Satyam Satyam (NYSE: SAY), a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and more than 65* countries. Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company's 52,865* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities. Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 690* clients, including 185* Fortune 500. For more information, see http://www.satyam.com. BizAuctions, Inc. (Pink Sheets: BZCN - http://finance.yahoo.com/q?s=BZCN.pk) December 15th, 2008-- BizAuctions, Inc. (Pink Sheets: BZCN), a prime provider of commercial eBay liquidation services for excess inventories and overstocks, announced today that its eleven-month revenues year-over-year increased approximately 29% over the same period in calendar year, 2007. Delmar Janovec, CEO, remarked, "BizAuctions revenues increased to approximately $3,075,797 for the eleven months ending November 30, 2008, representing an increase of approximately $698,192 or a 29% increase over the same eleven-month period in 2007." "We feel that year-over-year revenue growth of 29% for these eleven months is powerful even in a more healthy economy, so we feel very good about the 29% year-over-year revenue increase, in this challenging environment," Janovec added. Management is pleased with the growth since the inception of the Company, and is dedicated to building a major operation that will have a significant and positive impact on corporate America. Although the Company has not achieved profitability, and even though the monthly revenue ended November 30, 2008 decreased, this 29% year-over-year increase for the eleven-month period demonstrates the overall growth the Company has shown since its inception. With the excess inventory market near $60 billion, BizAuctions is targeting an enormous market and business opportunity while helping companies solve one of their greatest problems. The Company's clients have included some of the Nation's leading retail names at the forefront of their industries. With a long-term strategy to provide eBay liquidation services to Fortune 1000 enterprises, BizAuctions is a clear and lucrative solution for most any business to liquidate excess inventory on eBay. More information is available at www.BizAuctions.com. Investors and media can receive a free investor kit for BizAuctions, Inc. by contacting Investor Relations at [email protected] or (800) 961-3275. A virtual tour of BizAuctions' facilities and flash video presentation can be viewed at http://www.bizauctions.com/. ABOUT BIZAUCTIONS - ADDRESSING THE $60 BILLION PROBLEM BizAuctions, Inc. (Pink Sheets: BZCN) is a prime provider of commercial eBay liquidation services for excess inventory, overstock items, and returns. Our clients have included some of the Nation's leading retail names at the forefront of their industries. BizAuctions addresses the $60 billion excess inventory problem for clients by sending trucks to pick up pallets of excess inventory, selling the inventory on eBay, and collecting payment. We provide our clients with a new sales channel to generate additional revenue on excess inventory, while at the same time freeing up their valuable storage and retail space. With a long-term strategy to provide eBay liquidation services to Fortune 1000 enterprises, BizAuctions is a clear and lucrative solution for most any business to liquidate its excess inventory on eBay. The Company encourages the public to read the above information in conjunction with its year-end statement for December 31, 2007, and the quarterly statements filed in calendar year 2008, at www.PinkSheets.com. Anesiva, Inc. (Nasdaq: ANSV - http://finance.yahoo.com/q?s=ANSV) December 16th, 2008-- Anesiva, Inc. (Nasdaq: ANSV) today announced top-line results showing that the Phase 3 trial evaluating Adlea(TM), its long-acting, non-opioid analgesic drug candidate, achieved its primary efficacy endpoint of reducing post-surgical pain versus placebo (p=0.03) following total knee arthroplasty (TKA, or total knee replacement surgery) at four to 48 hours after surgery. The trial also met its key secondary endpoint with Adlea demonstrating a highly significant reduction in opioid medication consumption compared to placebo (p=0.005). Adlea is a long-acting, non-opioid drug candidate in development for the management of acute pain following orthopedic surgery. The Phase 3 TKA trial, known as ACTIVE-2 (Assessment of highly purified Capsaicin To ImproVE pain management after orthopedic surgery), also showed that Adlea's safety profile of adverse events, wound healing, and wound sensory function were similar to placebo over the study duration. "These compelling results confirm the analgesic contribution of Adlea during the most critical period following total knee arthroplasty with simultaneous opioid sparing effect, all without adding to the systemic side- effects commonly seen with opioids. These results suggest that Adlea has the potential to facilitate early rehabilitation in the knee replacement population," said William Houghton, M.D., Anesiva's senior vice president and chief medical officer. "The ACTIVE-2 data convincingly validate the value of the Adlea asset and will support our plans to partner or license this product candidate," said Michael L. Kranda, Anesiva's president and chief executive officer. "Over the past several months, we have revised the company's business model to significantly reduce our burn rate, and will achieve our goal of operating largely as a virtual company by year-end," Mr. Kranda said. "We now have retained a dedicated team ideally suited for Adlea clinical development and partnering within a cost structure that is appropriate for the current environment. With these positive developments, we look forward to rebuilding value for Anesiva through our virtual model, and through active partnering and licensing programs." ACTIVE-2 Details This multicenter, double-blind, placebo-controlled trial enrolled 217 patients undergoing total knee arthroplasty. Patients were randomized to receive either a single 60 mL dose of Adlea (0.25 mg/mL drug concentration) or placebo instilled into the surgical site immediately prior to wound closure. The primary efficacy endpoint was the area under the curve of patient pain scores, using a standard 0 to 10 numerical weighting system from four to 48 hours post-surgery. The study also evaluated rescue opioid consumption. Additional patient safety follow-up at two to six weeks after surgery demonstrated an advantage in pain management for Adlea versus placebo, with a similar safety profile. Adlea Phase 3 Results in Bunionectomy Surgeries A previous Phase 3 trial of Adlea, ACTIVE-1, in bunionectomy surgeries, demonstrated a highly statistically significant reduction in pain (p=0.004) from 4 to 48 hours post-surgery for Adlea-treated patients versus placebo, although the primary endpoint, pain at 4 to 32 hours post-surgery, narrowly failed to achieve statistical significance (p=0.07). The trial also achieved the key secondary endpoint of reducing opioid use for Adlea versus placebo (p=0.012) over the four to 32 hour period, and Adlea was well-tolerated. How Adlea May Address the Need for Long-Acting Pain Relief Adlea is a highly purified form of capsaicin (derived from chili peppers) that acts on TRPV1 receptors, expressed most densely in C-fiber neurons. Importantly, desensitization of the TRPV1 receptors blocks noxious pain with no effect on adaptive pain or position sense. Adlea generally has a short half-life of 1 to 2 hours. It is undetectable in the blood after 24 hours. Adlea's short duration of systemic exposure (hours) relative to the long duration of analgesia may offer a safe, additive treatment option in the management of orthopedic post-surgical pain. Importantly, Adlea appears to have a safety profile that is largely similar to placebo, in studies performed to date. About Total Knee Arthroplasty Total knee replacement (also known as total knee arthroplasty) is generally performed in patients with end-stage osteoarthritis of the knee. These patients have disabling pain which imposes severe limitations on their mobility, and knee replacement is performed with the goal of relieving pain and restoring mobility and knee function. There were an estimated 565,000 total knee replacement procedures performed in the United States in 2006, and the number of replacements will continue to grow as the average age of the U.S. population increases and as these individuals conduct more active lives. The American Academy of Orthopedic Surgeons projects that approximately 3.5 million of these procedures will be done each year by 2030. About Anesiva Anesiva, Inc. seeks to be a leader in the development of novel pharmaceutical products for pain management. The company's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. Adlea has been shown in previous clinical trials to provide extended pain relief after only a single administration in multiple indications for site-specific, acute and chronic, moderate-to-severe pain. Anesiva is based in South San Francisco, CA. For more information, go to www.anesiva.com. Please visit www.arcticoag.com and www.strategicnine.com Visit http://www.redhotpennystock.com to read our full disclaimer and/or sign up for our exceptional newsletter! Bull in Advantage, LLC Legal Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The employees are NOT Registered as Investment Advisors in any jurisdiction whatsoever. Also note that by submitting a request for a page on our website, or by signing up for our Newsletter you are explicitly consenting to have read, understood, and agreed to all of the terms set forth by this disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold Bull in Advantage, LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss(monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. Bull in Advantage, LLC does on occasion sell shares in the open market without notice, ; and on occasion is compensated by a Third-Party for its above-referenced services with the companys stock. Bull in Advantage, LLC reserves its right to sell such securities at any time and without notice.The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. Where such errors/omissions occur, the employees will expediently and without fail, correct said errors/omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Bull in Advantage, LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided, and explicitly consented by the companies profiled, OR is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. However, Bull in Advantage, LCC maintains that it will publish information which is accurate to the best of it's knowlegde. If at any time updated data becomes available, it is the responsibility of the employees to bring you said information in a timely manner. Bull in Advantage, LLC and its affiliates are not registered or liscenced investment advisors, nor broker dealers. Bull in Advantage, LLC advises that the investments in companies profiled are commonly considered to be high risk and use of the information provided is at the investor's sole risk. Bull in Advantage, LLC also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should never rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of r isk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Bull in Advantage, LLC makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through our services. Employees/Officers may or may not hold positions in the companies that are profiled. The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results. Third Party Web Sites and Information: The Bull in Advantage website and newsletter may provide hyperlinks to third party websites or access to third party content. Note that Bull in Advantage, LLC does not provide, control, endorse, or guarantee content found in such sites, except where clearly listed as having done so. (As in the case of a widespread Press-Release) You agree that Bull in Advantage, LLC is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that Bull in Advantage, LLC shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. CONTACT: Bull in Advantage, LLC e-mail: [email protected] WWW: http://bullinadvantage.com ((M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). Copyright ? 2008 M2 Communications Ltd. |